Teva Pharmaceutical Industries (TEVA) Shares Outstanding (2009 - 2026)
Teva Pharmaceutical Industries' Shares Outstanding was 1.17 billion in Q2 2026, up 1.6% from 1.15 billion a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Shares Outstanding (2009 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Teva Pharmaceutical Industries came in at 1.15 billion, up 1.2% from FY2024.
- Shares Outstanding has now increased for 12 consecutive years, with a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 1.13 billion in FY2024 (+1.1%), 1.12 billion in FY2023 (+0.8%), 1.11 billion in FY2022 (+0.7%) and 1.1 billion in FY2021 (+0.6%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding in data going back to Q1 2009.
- Compared with a year earlier, Shares Outstanding has increased for 47 straight quarters, with growth averaging 1.3% over the last eight quarters.
- Per Business Quant data, TEVA's Shares Outstanding in the three quarters before Q2 2026 was 1.16 billion (Q1 2026), 1.15 billion (Q4 2025) and 1.15 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,154.76 Bn | 1,123.35 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 624.99 Bn | 543.52 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 513.90 Bn | 487.02 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 366.41 Bn | 320.79 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 261.73 Bn | 235.41 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 235.10 Bn | 190.50 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.33 Bn | 118.98 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Teva Pharmaceutical Industries | 47.99 Bn | 34.83 Bn | 2.15 Bn | 1.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.16 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 1.15 Bn |
| Mar 31, 2025 | 1.14 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.12 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.11 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Sep 30, 2021 | 1.10 Bn |
API Access
Teva Pharmaceutical Industries Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();